Disruption of rcnB modulates colistin susceptibility in Acinetobacter baumannii AB5075
Yuying Zhang1, Jiabao Xing1,2, Hang Zhang1
1Department of Pharmacology and Toxicology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Abstract:
Acinetobacter baumannii AB5075 is a clinically relevant multidrug-resistant (MDR) isolate that poses a major therapeutic challenge. Although colistin has been reinstated as a last-resort antibiotic against MDR Gram-negative infections, the rapid emergence of colistin resistance threatens its clinical utility. Here, we employed a CRISPR-Cas9-based genome editing system to generate an A. baumannii AB5075 ΔrcnB mutant and uncovered a previously underappreciated role of rcnB in modulating colistin susceptibility. Loss of rcnB markedly potentiated colistin-mediated killing through multiple associated changes, including compromised membrane integrity, impaired oxidative stress defenses, and reduced efflux pump activity. Transcriptomic profiling further revealed that rcnB deletion reshaped global stress-response networks, including suppression of fatty acid biosynthesis and reactive oxygen species (ROS)-detoxifying pathways, alongside altered metal ion and sulfur metabolism during colistin exposure. Collectively, our findings suggest that rcnB may contribute to colistin susceptibility of colistin resistance and provide mechanistic insights that may inform the development of targeted strategies to enhance colistin efficacy against MDR A. baumannii.
Insights
The gene rcnB significantly impacts colistin resistance in Acinetobacter baumannii. Deleting rcnB increases susceptibility to colistin by affecting cell membrane integrity and stress defenses.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- Acinetobacter baumannii is a multidrug-resistant pathogen causing difficult-to-treat infections.
- Colistin is a last-resort antibiotic, but resistance is emerging rapidly.
- Understanding resistance mechanisms is crucial for effective treatment.
Purpose of the Study:
- To investigate the role of the rcnB gene in colistin susceptibility in Acinetobacter baumannii.
- To elucidate the molecular mechanisms by which rcnB affects antibiotic resistance.
Main Methods:
- Utilized CRISPR-Cas9 genome editing to create an rcnB deletion mutant (ΔrcnB) in A. baumannii AB5075.
- Performed transcriptomic profiling to analyze global gene expression changes.
- Assessed changes in membrane integrity, oxidative stress response, and efflux pump activity.
Main Results:
- Loss of rcnB significantly enhanced colistin-mediated killing.
- ΔrcnB mutant exhibited compromised membrane integrity and impaired oxidative stress defenses.
- Transcriptomic analysis revealed rcnB deletion altered stress-response networks, including fatty acid biosynthesis and ROS detoxification pathways.
Conclusions:
- rcnB plays a previously unrecognized role in modulating colistin susceptibility in A. baumannii.
- Mechanistic insights into rcnB function provide potential targets for enhancing colistin efficacy against multidrug-resistant strains.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Antibiotic Selection
Antimicrobial Effectiveness

